The Patriots waived Pharms on Saturday.
Pharms loses his 53-man roster spot to fellow DT Cory Durden, who was signed off the team's practice squad. Pharms appeared in 28 regular-season games for New England over the previous two seasons, logging 42 tackles (20 solo), including 2.0 sacks, and one fumble recovery. He could be an option to join the practice squad.
... See More... See Less
Patriots' Jeremiah Pharms: Returning to New England
Rotowire
Pharms agreed to a two-year contract extension with the Patriots on Monday, Mike Kadlick of CLNSMedia.com reports.
Pharms played in 16 regular-season contests with New England in 2024, tallying 33 tackles (16 solo), including 2.0 sacks. He saw his most action at the end of the campaign, logging at least 58 percent of the team's defensive snaps in each of his final three games. Pharms likely will continue to work in a rotational role for the Patriots next season.
... See More... See Less
Patriots' Jeremiah Pharms: Finishes 2024 with two sacks
Rotowire
Pharms played 16 regular-season games in 2024 and finished with 33 tackles (16 solo), including 2.0 sacks.
Pharms spent most of 2024 in a rotational role on the Patriots' defensive line behind starters Keion White, Daniel Ekuale and Davon Godchaux. However, Pharms did see an uptick in snaps late in the season, playing at least 34 defensive snaps in each of the final three regular-season games of 2024, during which he accumulated 13 tackles (six solo), including 1.0 sacks. Pharms is an exclusive rights free agent for 2025, which means he would be restricted to signing a contract with the Patriots if they offer one to him. If New England doesn't offer a contract to Pharms, then he would convert into an unrestricted free agent and would have the ability to sign with any team interested in his services.
